Skip to main content
Clinical Trials/ACTRN12609000085279
ACTRN12609000085279
Completed
未知

A double-blind, randomised study on the effects of STW 5 on symptoms and immunologic function in patients with irritable bowel syndrome

Royal Adelaide Hospital Gastroenterology and Hepatology0 sites60 target enrollmentFebruary 6, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Irritable Bowel Syndrome
Sponsor
Royal Adelaide Hospital Gastroenterology and Hepatology
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 6, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Adelaide Hospital Gastroenterology and Hepatology

Eligibility Criteria

Inclusion Criteria

  • Symptoms consitent with IBS according to the Rome III criteria; Not recieved antibiotics 8 wks prior; Not taking immunosuppressive medications;No Laxatives, no prokinetic drugs for 2 weeks;
  • Able to sign consent

Exclusion Criteria

  • Previous abdominal or gynaecological surgery (except appendectomies and cholecystectomies) previous gastrointestinal cancer;Known peptic ulcers;pregnancy or breastfeeding;chronic inflammatory disease, cardiovascular disease; respiratory disease;Diabetes mellitus; Epilepsy;

Outcomes

Primary Outcomes

Not specified

Similar Trials